World News | Associated Press | Thursday August 7, 2014
The use of an experimental drug to treat two Americans diagnosed with Ebola is raising ethical questions about who gets first access to unproven new therapies for the deadly disease. But some health experts fear that debate over extremely limited doses will distract from tried-and-true measures to curb the growing outbreak, like more rapidly identi...
www.ndtv.com